Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Department of Hepato-Pancreato-Biliary Surgery and Liver Transplantation, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Br J Cancer. 2020 Jul;123(2):196-206. doi: 10.1038/s41416-020-0881-z. Epub 2020 May 18.
Patients with resected colorectal liver metastasis (CRLM) who display only the desmoplastic histopathological growth pattern (dHGP) exhibit superior survival compared to patients with any non-desmoplastic growth (non-dHGP). The aim of this study was to compare the tumour microenvironment between dHGP and non-dHGP.
The tumour microenvironment was investigated in three cohorts of chemo-naive patients surgically treated for CRLM. In cohort A semi-quantitative immunohistochemistry was performed, in cohort B intratumoural and peritumoural T cells were counted using immunohistochemistry and digital image analysis, and in cohort C the relative proportions of individual T cell subsets were determined by flow cytometry.
One hundred and seventeen, 34, and 79 patients were included in cohorts A, B, and C, with dHGP being observed in 27%, 29%, and 15% of patients, respectively. Cohorts A and B independently demonstrated peritumoural and intratumoural enrichment of cytotoxic CD8+ T cells in dHGP, as well as a higher CD8+/CD4+ ratio (cohort A). Flow cytometric analysis of fresh tumour tissues in cohort C confirmed these results; dHGP was associated with higher CD8+ and lower CD4+ T cell subsets, resulting in a higher CD8+/CD4+ ratio.
The tumour microenvironment of patients with dHGP is characterised by an increased and distinctly cytotoxic immune infiltrate, providing a potential explanation for their superior survival.
与任何非促结缔组织增生型(non-dHGP)生长的患者相比,显示出促结缔组织增生型(dHGP)组织病理学生长模式的结直肠癌肝转移(CRLM)患者的生存情况更佳。本研究旨在比较 dHGP 和非 dHGP 之间的肿瘤微环境。
对三组接受初次化疗的 CRLM 手术治疗的患者进行肿瘤微环境研究。在队列 A 中进行半定量免疫组化,在队列 B 中使用免疫组化和数字图像分析计数肿瘤内和肿瘤周围的 T 细胞,在队列 C 中通过流式细胞术确定各 T 细胞亚群的相对比例。
队列 A、B 和 C 分别纳入了 117、34 和 79 例患者,dHGP 分别占 27%、29%和 15%。队列 A 和 B 独立显示 dHGP 中肿瘤周围和肿瘤内细胞毒性 CD8+T 细胞的富集,以及更高的 CD8+/CD4+比值(队列 A)。在队列 C 中对新鲜肿瘤组织的流式细胞术分析证实了这些结果;dHGP 与更高的 CD8+和更低的 CD4+T 细胞亚群相关,导致更高的 CD8+/CD4+比值。
dHGP 患者的肿瘤微环境的特点是免疫浸润增加且明显具有细胞毒性,这为其更好的生存情况提供了潜在解释。